130 related articles for article (PubMed ID: 16470722)
21. Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy.
Huck JH; Verhoeven NM; Struys EA; Salomons GS; Jakobs C; van der Knaap MS
Am J Hum Genet; 2004 Apr; 74(4):745-51. PubMed ID: 14988808
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial involvement and erythronic acid as a novel biomarker in transaldolase deficiency.
Engelke UF; Zijlstra FS; Mochel F; Valayannopoulos V; Rabier D; Kluijtmans LA; Perl A; Verhoeven-Duif NM; de Lonlay P; Wamelink MM; Jakobs C; Morava E; Wevers RA
Biochim Biophys Acta; 2010 Nov; 1802(11):1028-35. PubMed ID: 20600873
[TBL] [Abstract][Full Text] [Related]
23. Transaldolase deficiency in a two-year-old boy with cirrhosis.
Wamelink MM; Struys EA; Salomons GS; Fowler D; Jakobs C; Clayton PT
Mol Genet Metab; 2008 Jun; 94(2):255-8. PubMed ID: 18331807
[TBL] [Abstract][Full Text] [Related]
24. Adherence to Bürgi-Dunitz stereochemical principles requires significant structural rearrangements in Schiff-base formation: insights from transaldolase complexes.
Light SH; Minasov G; Duban ME; Anderson WF
Acta Crystallogr D Biol Crystallogr; 2014 Feb; 70(Pt 2):544-52. PubMed ID: 24531488
[TBL] [Abstract][Full Text] [Related]
25. [A newly discovered metabolic diseases due to defects in the pentose pathway].
Tylki-Szymańska A; Stradomska TJ
Postepy Biochem; 2011; 57(2):168-71. PubMed ID: 21913417
[TBL] [Abstract][Full Text] [Related]
26. Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis.
Banki K; Colombo E; Sia F; Halladay D; Mattson DH; Tatum AH; Massa PT; Phillips PE; Perl A
J Exp Med; 1994 Nov; 180(5):1649-63. PubMed ID: 7964452
[TBL] [Abstract][Full Text] [Related]
27. Comparison of capillary electrophoresis-mass spectrometry and hydrophilic interaction chromatography-mass spectrometry for anionic metabolic profiling of urine.
Kok MG; Somsen GW; de Jong GJ
Talanta; 2015 Jan; 132():1-7. PubMed ID: 25476271
[TBL] [Abstract][Full Text] [Related]
28. Deletion of Ser-171 causes inactivation, proteasome-mediated degradation and complete deficiency of human transaldolase.
Grossman CE; Niland B; Stancato C; Verhoeven NM; Van Der Knaap MS; Jakobs C; Brown LM; Vajda S; Banki K; Perl A
Biochem J; 2004 Sep; 382(Pt 2):725-31. PubMed ID: 15115436
[TBL] [Abstract][Full Text] [Related]
29. An alternative pentose phosphate pathway in human gut bacteria for the degradation of C5 sugars in dietary fibers.
Garschagen LS; Franke T; Deppenmeier U
FEBS J; 2021 Mar; 288(6):1839-1858. PubMed ID: 32770699
[TBL] [Abstract][Full Text] [Related]
30. Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) Activities in normal, neoplastic, differentiating, and regenerating liver.
Heinrich PC; Morris HP; Weber G
Cancer Res; 1976 Sep; 36(9 pt.1):3189-97. PubMed ID: 10080
[TBL] [Abstract][Full Text] [Related]
31. mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency.
Winans T; Oaks Z; Choudhary G; Patel A; Huang N; Faludi T; Krakko D; Nolan J; Lewis J; Blair S; Lai Z; Landas SK; Middleton F; Asara JM; Chung SK; Wyman B; Azadi P; Banki K; Perl A
J Autoimmun; 2023 Nov; 140():103112. PubMed ID: 37742509
[TBL] [Abstract][Full Text] [Related]
32. The significance of sedoheptulose 1,7-bisphosphate in the metabolism and regulation of the pentose pathway in liver.
Williams JF; Blackmore PF; Arora KK
Biochem Int; 1985 Oct; 11(4):599-610. PubMed ID: 4084320
[TBL] [Abstract][Full Text] [Related]
33. Determination of active components of Ginkgo biloba in human urine by capillary high-performance liquid chromatography/mass spectrometry with on-line column-switching purification.
Ding S; Dudley E; Chen L; Plummer S; Tang J; Newton RP; Brenton AG
Rapid Commun Mass Spectrom; 2006; 20(24):3619-24. PubMed ID: 17094168
[TBL] [Abstract][Full Text] [Related]
34. Transaldolase/glucose-6-phosphate isomerase bifunctional enzyme and ribulokinase as factors to increase xylitol production from D-arabitol in Gluconobacter oxydans.
Sugiyama M; Suzuki S; Tonouchi N; Yokozeki K
Biosci Biotechnol Biochem; 2003 Dec; 67(12):2524-32. PubMed ID: 14730129
[TBL] [Abstract][Full Text] [Related]
35. Clinical and molecular characteristics of two transaldolase-deficient patients.
Tylki-Szymanska A; Wamelink MM; Stradomska TJ; Salomons GS; Taybert J; Dąbrowska-Leonik N; Rurarz M
Eur J Pediatr; 2014 Dec; 173(12):1679-82. PubMed ID: 24497183
[TBL] [Abstract][Full Text] [Related]
36. Converting Transaldolase into Aldolase through Swapping of the Multifunctional Acid-Base Catalyst: Common and Divergent Catalytic Principles in F6P Aldolase and Transaldolase.
Sautner V; Friedrich MM; Lehwess-Litzmann A; Tittmann K
Biochemistry; 2015 Jul; 54(29):4475-86. PubMed ID: 26131847
[TBL] [Abstract][Full Text] [Related]
37. Speciation of selenium compounds by open tubular capillary electrochromatography-inductively coupled plasma mass spectrometry.
Lin SY; Wang GR; Huang QP; Liu CY
Electrophoresis; 2006 Nov; 27(21):4257-65. PubMed ID: 17001743
[TBL] [Abstract][Full Text] [Related]
38. Twisted Schiff base intermediates and substrate locale revise transaldolase mechanism.
Lehwess-Litzmann A; Neumann P; Parthier C; Lüdtke S; Golbik R; Ficner R; Tittmann K
Nat Chem Biol; 2011 Aug; 7(10):678-84. PubMed ID: 21857661
[TBL] [Abstract][Full Text] [Related]
39. The measurement of xylulose 5-phosphate, ribulose 5-phosphate, and combined sedoheptulose 7-phosphate and ribose 5-phosphate in liver tissue.
Casazza JP; Veech RL
Anal Biochem; 1986 Dec; 159(2):243-8. PubMed ID: 3826613
[TBL] [Abstract][Full Text] [Related]
40. Quantification of pentose phosphate pathway (PPP) metabolites by liquid chromatography-mass spectrometry (LC-MS).
Jannasch A; Sedlak M; Adamec J
Methods Mol Biol; 2011; 708():159-71. PubMed ID: 21207289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
